Los Angeles, April 14, 2015 (GLOBE NEWSWIRE) -- BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces that the Company's pilot program that was created as a result of an agreement with Myriad Medical Marketing (MMM) is scheduled to launch later this month. As of April 27, 2015 Corona Physical Medicine (CPM) in Corona, CA plans to begin setting appointments with potential patients. CPM is located at 1150 El Camino Avenue, Suite 108, Corona, CA 92879. This will be the first of five planned locations to participate in the Start Fresh pilot program. Upon successful completion of the pilot program, MMM will begin to introduce the Start Fresh Program to other wellness centers nationwide.
"We are excited about the launch of the pilot program, as it is the first step towards executing on our desire to expand to numerous established wellness centers throughout the country. We believe that the relationships with these centers will be highly beneficial to those who need help with their addiction. We believe that the broad range of wellness services available to patients affords the opportunity to create highly customizable courses of treatment to not only recover from addiction, but to reclaim their overall health," stated COO & interim CEO, Brady Granier.
Corona Physical Medicine is a holistic wellness center owned by Dr. Jon Brunelle, founder of Myriad Medical Marketing. CPM's philosophy of integrative medicine can be highly beneficial to patients who undergo the Start Fresh Program. The center offers chiropractic care, acupuncture, massage, nutrition, and hydration therapy among other services. "We are excited to combine our knowledge of holistic healing and overall wellness with the tools offered by the Start Fresh Program. Access to this program through our wellness center is wonderful news for residents of the Inland Empire" stated Dr. Brunelle.
Visit BioCorRx, Inc.'s investor relations website www.BICXcorp.com to receive the most up to date company information.
About BioCorRx, Inc.
BioCorRx, Inc. ® (OTCQB: BICX) is an addiction treatment and rehabilitation company offering a unique approach to the treatment of substance abuse addiction. The Start Fresh Program® consists of two components. The first component of the program consists of an outpatient implant procedure performed by a licensed physician. The implant delivers therapeutic levels of the drug Naltrexone, an opioid antagonist that significantly reduces physical cravings for alcohol and opioids, into the body. The second component of the program developed by BioCorRx, Inc. is a one on one coaching program specifically tailored for the treatment of alcoholism and other substance abuse addictions. Clinic reports show that the treatment program can be successful for individuals who complete the program. For more information on BICX, visit www.BioCorRx.com
2014 was a pivotal year for BioCorRx, Inc. Clinics using the Start Fresh Program collectively saw a 402% increase in patients treated from 2013 to 2014. Over the course of 2015, the company plans to continue the process of developing more new territories with its partners.
Number of clinics at the end of each quarter offering the Start Fresh Program
-Q1, 2014 -- 5 clinics offering the Start Fresh Program
-Q2, 2014 -- 6 clinics offering the Start Fresh Program
-Q3, 2014 -- 6 clinics offering the Start Fresh Program
-Q4, 2014 -- 10 clinics offering the Start Fresh Program
-Q1, 2015 - 13 clinics offering the Start Fresh Program
Safe Harbor Statement
The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.
CONTACT: Investor Relations SmallCapVoice.com, Inc. 512-267-2430